10 results
Drugs Used for the Treatment of COVID-19 Infection

** Editor Note (from ophthalmology MD input) - Hydroxychloroquine/chloroquine
Drugs Used for the ... Treatment of COVID ... -19 Infection ... highlighted circle= clinical ... #Table #Management
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
IDSA - Clinical ... Individualized Treatment ... are contacts of infectious ... Tuberculosis #MDRTB #management ... #idsa #drugs #steps
C.diff - Clostridioides Difficile Infection (CDI) - Diagnosis and Management - GrepMed Handbook

Clinical Presentation + Progression:
Clostridioides Difficile Infection ... Diagnosis and Management ... GrepMed Handbook Clinical ... (IDSA 2021): ... mg PO qd - If needing
Induction agents used in anesthesia play a key role in the eventual sedation of the patient,
of the patient, leading ... #clinical #management ... Amidate (etomidate) dosing ... reference.medscape.com/drug ... Effects, Dosages, Treatment
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
IDSA Recommendations ... a person with infectious ... HIV-infected persons with clinical ... Tuberculosis #TB #IDSA ... #management #opportunistic
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
drug use • Silicosis ... involvement - seeding ... characteristic features Clinical ... TB #Diagnosis #Management ... #Treatment #ActiveTB
Aplastic Anemia - Overview

Who?
• M = F
• 3 peaks:	1) Childhood	2) 15-25 years	3) >60 years

What?
• Aplastic anemia
Aplastic Anemia Clinical ... ecchymoses, mucosal bleeding ... - Cytotoxic drugs ... aplastic anemia Treatment ... hematology #diagnosis #management
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
drug use • Silicosis ... involvement - seeding ... characteristic features Clinical ... TB #Diagnosis #Management ... #Treatment #ActiveTB
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS
Preventing 1st Episode of Disseminated
IDSA Recommendations ... disease based on clinical ... #Prevention #Treatment ... #management #opportunistic ... #infections #HIVAIDS
Macrophage Activation Syndrome (MAS)
Classified among the secondary or acquired forms of haemophagocytic lymphohistiocytosis (sHLH)

What?
A subset of
purpura to mucosal bleeding ... SLE], AOSD) • Infection ... ) • Sepsis • Drug-induced ... Treatment: • Corticosteroids ... Syndrome #Diagnosis #Management